Surfixdx
1 known investors
Surfix develops a photonic diagnostics platform, combining a photonic biosensor chip with microfluidic cartridges and a desktop reader, to enable point-of-care testing for disease detection and monitoring. The platform is co-developed with partners for applications including drug development, antibiotic susceptibility testing, and diagnosis of conditions such as cancer and cardiovascular disease.